https://www.indianpharmapost.com/innocare-pharma-gets-green-light-for-phase-ii-trial-of-oral-lupus-drug-186852025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/ab-science-secures-us-patent-for-masitinib-in-sickle-cell-disease-till-2040-186982025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/nona-biosciences-expands-platform-to-accelerate-early-clinical-trials-186972025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/edwards-lifesciences-sapien-m3-becomes-first-fda-approved-transseptal-mitral-valve-replacement-186962025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/amneal-and-mabxience-score-fda-green-light-for-two-denosumab-biosimilars-186952025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/irlab-launches-phase-ib-trial-of-irl757-for-parkinsons-patients-with-apathy-186942025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/symbiosis-rolls-out-first-10000-vial-batch-at-stirling-facility-186932025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/zeon-corporation-to-acquire-ushios-microfluidics-biz-186922025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/chugais-tecentriq-gets-green-light-in-japan-for-hard-to-treat-thymic-carcinoma-186912025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/eu-nod-to-wayrilz-as-breakthrough-treatment-for-hard-to-treat-itp-186902025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/who-report-reveals-stark-global-inequities-in-genomic-research-186892025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/health-minister-nadda-to-launch-indian-pharmacopoeia-2026-in-the-first-week-of-jan-2026-186882025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-setback-for-sanofis-tolebrutinib-in-progressive-ms-186872025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/ginkgo-bioworks-teams-with-carnegie-mellon-on-cancer-detection-program-186862025-12-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-okays-aqvesme-as-first-treatment-for-anemia-in-alpha-beta-thalassemia-186992025-12-27T00:00:00+05:30always0.9